PubMed HealthSearch

PubMed · 7320663

Problems in data management when studying chronic illness.

Abstract

Chronic illness is characterized by a long response time during which many external influences can modify the system. Accurate characterization of such a system may require a large number of attributes. Such "data" complexity, in both the time and the feature domain, introduces a number of operational difficulties into the methodology for the scientific investigation of such systems. One such problem is the investigator's changing viewpoint and understanding of the system during the course of a study. Research data bases with a static attribute content are in conflict with this learning process and are of limited use when incorporated in investigation of chronic illness. Data element refinement is a tool for dealing with this problem, by providing a means for modifying an attribute's definition during the temporal life of a data base. We have been investigating means for supporting refinement of data elements in a large data base for coronary artery disease. For certain data types, we have developed a means of introducing "refined" views of particular data elements into a data base such that programs written prior to the refinement execute properly without modification during the lifetime of the data base. We will describe a data structure we have found suitable for capturing the information base from a broad range of clinical investigations, and our approach to the problem of data element refinement. Examples from ongoing clinical studies will be used to illustrate these ideas.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C F Starmer, D A Smith, J S Wells, B C Wright. 1981. Problems in data management when studying chronic illness.. https://doi.org/10.1007/bf02222145

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Glaucoma, lighting and color vision. An investigation into their interrelationship.

The results of a study on color vision capacity performed with a view to further analyzing glaucomatous dyschromatopsia are reported. The Farnsworth-Munsell 100-hue test was used in a population of 52 subjects (104 eyes) with daylight fluorescent lighting and low-tension halogen lighting. Photocolorimetric observations with each type of lighting were made. It was found that halogen lighting increased the glaucomatous subjects' mean score, the number of dyschromatopsia and the number of blue-yellow dyschromatopsia axes. The authors conclude that halogen lighting is preferable for the Farnsworth-Munsell 100-hue test in glaucoma and confirm the predominance of blue-yellow dyschromatopsia axes in glaucoma.

Chronic Disease

The physician's role in controlling health care costs.

Choices about referrals, tests, and prescriptions offer physicians many opportunities to reduce health care costs. Some commonsense measures are described, and the principles to which cost-effectiveness analyses should adhere are explained.

Chronic Disease

Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor.

Living-related donor liver transplantation (LDLT) is an accepted approach to pediatric liver transplantation. Parental donation imposes a significant risk of chimerism with graft-versus-host disease (GVHD) because donors homozygous at all HLA loci (1.6% of the population) present no mismatched HLA antigens to be recognized by their offspring's immune system. The case of a 9-month-old who underwent LDLT with her 23-year-old HLA-homozygous mother as a donor demonstrates the consequences of this occurrence. The patient developed GVHD with aplastic anemia; the patient's nucleated peripheral blood elements were shown to be entirely derived from the donor. Later, after some marrow recovery, the patient's circulating lymphocytes had a donor origin, while the marrow-derived neutrophils had a recipient origin. The patient suffers from chronic GVHD and debilitating skin disease several years posttransplant. Our current protocol calls for HLA typing to eliminate parents who are homozygous at all HLA loci as donors of hepatic allografts to their children.

Chronic Disease